Literature DB >> 19535770

Clinical spectrum of ataxia-telangiectasia in adulthood.

M M M Verhagen1, W F Abdo, M A A P Willemsen, F B L Hogervorst, D F C M Smeets, J A P Hiel, E R Brunt, M A van Rijn, D Majoor Krakauer, R A Oldenburg, A Broeks, J I Last, L J van't Veer, M A J Tijssen, A M I Dubois, H P H Kremer, C M R Weemaes, A M R Taylor, M van Deuren.   

Abstract

OBJECTIVE: To describe the phenotype of adult patients with variant and classic ataxia-telangiectasia (A-T), to raise the degree of clinical suspicion for the diagnosis variant A-T, and to assess a genotype-phenotype relationship for mutations in the ATM gene.
METHODS: Retrospective analysis of the clinical characteristics and course of disease in 13 adult patients with variant A-T of 9 families and 6 unrelated adults with classic A-T and mutation analysis of the ATM gene and measurements of ATM protein expression and kinase activity.
RESULTS: Patients with variant A-T were only correctly diagnosed in adulthood. They often presented with extrapyramidal symptoms in childhood, whereas cerebellar ataxia appeared later. Four patients with variant A-T developed a malignancy. Patients with classic and variant A-T had elevated serum alpha-fetoprotein levels and chromosome 7/14 rearrangements. The mildest variant A-T phenotype was associated with missense mutations in the ATM gene that resulted in expression of some residual ATM protein with kinase activity. Two splicing mutations, c.331 + 5G>A and c.496 + 5G>A, caused a more severe variant A-T phenotype. The splicing mutation c.331 + 5G>A resulted in less ATM protein and kinase activity than the missense mutations.
CONCLUSIONS: Ataxia-telangiectasia (A-T) should be considered in patients with unexplained extrapyramidal symptoms. Early diagnosis is important given the increased risk of malignancies and the higher risk for side effects of subsequent cancer treatment. Measurement of serum alpha-fetoprotein and chromosomal instability precipitates the correct diagnosis. There is a clear genotype-phenotype relation for A-T, since the severity of the phenotype depends on the amount of residual kinase activity as determined by the genotype.

Entities:  

Mesh:

Year:  2009        PMID: 19535770     DOI: 10.1212/WNL.0b013e3181af33bd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

1.  Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Authors:  Virginie Jacquemin; Guillaume Rieunier; Sandrine Jacob; Dorine Bellanger; Catherine Dubois d'Enghien; Anthony Laugé; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Homozygosity for c 6325T>G transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia.

Authors:  Gabriella Silvestri; Marcella Masciullo; Maria Piane; Camilla Savio; Anna Modoni; Massimo Santoro; Luciana Chessa
Journal:  J Neurol       Date:  2010-05-18       Impact factor: 4.849

3.  Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Authors:  Jana Soukupova; Petr Pohlreich; Eva Seemanova
Journal:  Neuromolecular Med       Date:  2011-08-11       Impact factor: 3.843

Review 4.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

5.  Novel ATM mutation in a German patient presenting as generalized dystonia without classical signs of ataxia-telangiectasia.

Authors:  Christoph Kuhm; Constanze Gallenmüller; Thilo Dörk; Moritz Menzel; Saskia Biskup; Thomas Klopstock
Journal:  J Neurol       Date:  2015-01-09       Impact factor: 4.849

6.  Dopa-Responsive Dystonia and Chorea as a Presenting Feature in Ataxia-Telangiectasia.

Authors:  Sarah Thompson; Anand Iyer; Philip Byrd; Malcolm Taylor; Stefan Spinty
Journal:  Mov Disord Clin Pract       Date:  2014-06-11

7.  Bilateral Deep Brain Stimulation of the Globus Pallidus Pars Interna in a Patient with Variant Ataxia-Telangiectasia.

Authors:  Dejan Georgiev; Dwij Mehta; André Zacharia; Ruben Saman Vinke; Catherine Milabo; Joseph Candelario; Elina Tripoliti; Jonathan A Hyam; Ludvic Zrinzo; Marwan Hariz; Seán O'Riordan; Thomas Foltynie; Patricia Limousin
Journal:  Mov Disord Clin Pract       Date:  2016-01-21

8.  Novel mutation in the ATM gene in a Malian family with ataxia telangiectasia.

Authors:  Guida Landouré; Fanny Mochel; Katherine Meilleur; Madani Ly; Modibo Sangaré; Nouhoum Bocoum; Koumba Bagayoko; Thomas Coulibaly; Amadou M Sarr; Hamidou O Bâ; Souleymane Coulibaly; Cheick O Guinto; Mahamadou Touré; Moussa Traoré; Kenneth H Fischbeck
Journal:  J Neurol       Date:  2012-11-11       Impact factor: 4.849

Review 9.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

10.  Clinical experience in T cell deficient patients.

Authors:  Theresa S Cole; Andrew J Cant
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-13       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.